SOPHiA GENETICS (SOPH) News Today $3.03 +0.01 (+0.33%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$3.28 +0.25 (+8.22%) As of 05/2/2025 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period SOPHiA GENETICS (SOPH) Projected to Post Earnings on TuesdaySOPHiA GENETICS (NASDAQ:SOPH) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-sophia-genetics-sa-stock/)May 1, 2025 | marketbeat.comSOPHiA GENETICS expands AstraZeneca liquid biopsy testApril 30, 2025 | investing.comSOPHiA GENETICS Expands AstraZeneca Partnership to Advance Liquid Biopsy WorldwideApril 29, 2025 | msn.comSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACRApril 28, 2025 | prnewswire.comSOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025April 22, 2025 | prnewswire.comSophia Genetics, Precision for Medicine enter strategic partnershipApril 9, 2025 | markets.businessinsider.comPrecision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy CapabilitiesApril 8, 2025 | prnewswire.comSOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest UpdateSOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 48,500 shares, a decrease of 21.5% from the February 28th total of 61,800 shares. Based on an average trading volume of 75,800 shares, the days-to-cover ratio is presently 0.6 days. Approximately 0.1% of the shares of the stock are short sold.April 1, 2025 | marketbeat.comMorgan Stanley Keeps Their Hold Rating on SOPHiA GENETICS (SOPH)March 20, 2025 | markets.businessinsider.comSOPHiA GENETICS (SOPH) Gets a Buy from BTIGMarch 18, 2025 | markets.businessinsider.comSOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTCMarch 18, 2025 | prnewswire.comShort Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 64.4%SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a significant growth in short interest in February. As of February 28th, there was short interest totalling 61,800 shares, a growth of 64.4% from the February 13th total of 37,600 shares. Based on an average daily volume of 74,500 shares, the short-interest ratio is currently 0.8 days. Approximately 0.1% of the shares of the company are short sold.March 16, 2025 | marketbeat.comSOPHiA GENETICS (SOPH) Receives a Buy from BTIGMarch 12, 2025 | markets.businessinsider.comBaby Sophia from embryo swap will stay with birth parents court rules on appealMarch 11, 2025 | msn.comDistrict Court rules to keep IVF child with birth mother following embryo mix-upMarch 10, 2025 | msn.comCourt overturns ruling that ordered toddler returned to genetic parents following embryo mix-upMarch 10, 2025 | msn.comSophia Genetics price target lowered to $5 from $6 at BTIGMarch 6, 2025 | markets.businessinsider.comSOPHiA GENETICS (SOPH) Gets a Buy from RBC CapitalMarch 5, 2025 | markets.businessinsider.comSOPHiA GENETICS SA (NASDAQ:SOPH) Q4 2024 Earnings Call TranscriptMarch 5, 2025 | msn.comSOPHiA GENETICS Full Year 2024 Earnings: In Line With ExpectationsMarch 5, 2025 | finance.yahoo.comSOPHiA GENETICS SA (SOPH) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | seekingalpha.comSophia Genetics sees FY25 revenue $72M-$76M, consensus $74.51MMarch 4, 2025 | markets.businessinsider.comCraig-Hallum Sticks to Its Buy Rating for SOPHiA GENETICS (SOPH)March 4, 2025 | markets.businessinsider.comSOPHiA GENETICS (NASDAQ:SOPH) Issues Earnings ResultsSOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.23) EPS for the quarter, meeting the consensus estimate of ($0.23). SOPHiA GENETICS had a negative return on equity of 55.06% and a negative net margin of 110.71%.March 4, 2025 | marketbeat.comSOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 ResultsMarch 4, 2025 | prnewswire.comSOPHiA GENETICS SA (NASDAQ:SOPH) Sees Large Growth in Short InterestSOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) saw a significant increase in short interest during the month of February. As of February 15th, there was short interest totalling 37,600 shares, an increase of 89.9% from the January 31st total of 19,800 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily volume of 69,500 shares, the days-to-cover ratio is presently 0.5 days.March 2, 2025 | marketbeat.comSOPHiA GENETICS: Leading Healthcare Institutions Adopt MSK-ACCESS for Liquid Biopsy TestingFebruary 24, 2025 | finanznachrichten.deSophia Genetics announces adoption of MSK-AccessFebruary 24, 2025 | markets.businessinsider.comLeading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy TestingFebruary 24, 2025 | prnewswire.comSOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025February 18, 2025 | prnewswire.comSOPHiA GENETICS SA (NASDAQ:SOPH) Sees Large Drop in Short InterestSOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 19,800 shares, a drop of 34.0% from the January 15th total of 30,000 shares. Approximately 0.0% of the company's shares are short sold. Based on an average daily volume of 53,500 shares, the short-interest ratio is currently 0.4 days.February 15, 2025 | marketbeat.comOne-year-old's rare disorder which leaves her always 'starving'February 15, 2025 | uk.news.yahoo.comWhat a $2 Million Per Dose Gene Therapy Reveals About Drug PricingFebruary 13, 2025 | msn.comSOPHiA GENETICS (NASDAQ:SOPH) Shares Down 4.4% - Here's WhySOPHiA GENETICS (NASDAQ:SOPH) Trading Down 4.4% - Here's WhyFebruary 12, 2025 | marketbeat.comRBC Capital Sticks to Their Buy Rating for SOPHiA GENETICS (SOPH)February 6, 2025 | markets.businessinsider.comSOPHiA GENETICS Launches Comprehensive MRD Tracking CapabilitiesJanuary 28, 2025 | prnewswire.comHealthcare Analytics Industry to Hit USD 133.1 billion by 2029 with 24.3% CAGR | MarketsandMarkets™January 21, 2025 | finance.yahoo.comCancer Biopsy Market Size is Expected to Reach USD 60.92 Billion by 2033, Growing at a CAGR of 7.81%: Straits ResearchJanuary 20, 2025 | finance.yahoo.comShort Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Decreases By 15.1%SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) saw a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 31,400 shares, a decrease of 15.1% from the December 15th total of 37,000 shares. Based on an average daily trading volume, of 25,600 shares, the short-interest ratio is presently 1.2 days. Currently, 0.1% of the shares of the stock are short sold.January 16, 2025 | marketbeat.comMorgan Stanley Reaffirms Their Hold Rating on SOPHiA GENETICS (SOPH)January 14, 2025 | markets.businessinsider.comShort Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 38.6%SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 37,000 shares, a growth of 38.6% from the November 30th total of 26,700 shares. Based on an average daily volume of 24,300 shares, the days-to-cover ratio is currently 1.5 days. Currently, 0.1% of the company's stock are short sold.December 29, 2024 | marketbeat.comCraig-Hallum Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy RecommendationDecember 19, 2024 | msn.comCraig-Hallum bullish on Sophia Genetics, initiates with a BuyDecember 18, 2024 | markets.businessinsider.comCraig Hallum Initiates Coverage on SOPHiA GENETICS (NASDAQ:SOPH)Craig Hallum started coverage on shares of SOPHiA GENETICS in a research note on Wednesday. They set a "buy" rating and a $11.00 price objective on the stock.December 18, 2024 | marketbeat.comShort Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Drops By 52.7%SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the target of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 26,700 shares, a decline of 52.7% from the November 15th total of 56,500 shares. Based on an average trading volume of 26,800 shares, the short-interest ratio is presently 1.0 days. Approximately 0.1% of the shares of the stock are sold short.December 12, 2024 | marketbeat.comSOPHiA GENETICS (SOPH) Receives a Buy from RBC CapitalDecember 11, 2024 | markets.businessinsider.comSOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024November 21, 2024 | prnewswire.comMorgan Stanley Sticks to Its Hold Rating for SOPHiA GENETICS (SOPH)November 19, 2024 | markets.businessinsider.comEarnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00November 8, 2024 | finance.yahoo.comSophia Genetics (NASDAQ:SOPH) Stock Quotes, Forecast and News SummaryNovember 6, 2024 | benzinga.com Get SOPHiA GENETICS News Delivered to You Automatically Sign up to receive the latest news and ratings for SOPH and its competitors with MarketBeat's FREE daily newsletter. Email Address SOPH Media Mentions By Week SOPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SOPH News Sentiment▼0.100.73▲Average Medical News Sentiment SOPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SOPH Articles This Week▼42▲SOPH Articles Average Week Get SOPHiA GENETICS News Delivered to You Automatically Sign up to receive the latest news and ratings for SOPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AVDL News VIR News AVXL News BCAX News CMRX News CDMO News DAWN News OCS News CVAC News SYRE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SOPH) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SOPHiA GENETICS SA Please log in to your account or sign up in order to add this asset to your watchlist. Share SOPHiA GENETICS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SOPH Stock Free SOPH Stock Alerts